Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Elevance Health Inc.

Stifel Nicolaus analyst Dara Azar reiterated a Buy rating on Enliven Therapeutics today and set a price target of $82.00. According to TipRanks, Az...

Enliven Therapeutics (ELVN) Gets a Buy from Stifel Nicolaus

Electrovaya ( ($TSE:ELVA) ) has issued an update. Electrovaya reported third-quarter fiscal 2026 revenue of $17.7 million, up about 3% year over ye...

Electrovaya posts record margins and deepens Amazon ties with new storage platform

Elevra Lithium ( ($AU:ELV) ) has issued an announcement. Elevra Lithium has completed the sale of all rights, interests and obligations over explor...

Elevra Lithium Sells Tabba Tabba Pegmatite Rights to Fund North American Growth

Elevra Lithium ( ($AU:ELV) ) has shared an update. Elevra Lithium reported a strong June 2026 quarter at its North American Lithium mine, with reco...

Elevra Lithium boosts output and locks in funding for North American expansion

Bernstein analyst Lance Wilkes maintained a Buy rating on Elevance Health yesterday and set a price target of $488.00. The company’s shares closed ...

Elevance Health (ELV) Gets a Buy from Bernstein

Elevra Lithium ( ($AU:ELV) ) just unveiled an announcement. Elevra Lithium has scheduled the release of its June 2026 Quarterly Activities Report f...

Elevra Lithium Sets Date for June Quarter Results Webcast

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Iovance Biotherapeutics (IOVA), Elevance Health (E...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Iovance Biotherapeutics (IOVA), Elevance Health (ELV) and InnovAge Holding (INNV)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 10x Genomics (TXG), Elevance Health (ELV) and John...

Analysts Have Conflicting Sentiments on These Healthcare Companies: 10x Genomics (TXG), Elevance Health (ELV) and Johnson & Johnson (JNJ)

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on EasyJet (EJTTF) and Electrovaya (ELVA). EasyJet (EJTTF) In ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ELV	$400.32	0.00%	652.29K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ELV	$400.32	0%	652.29K
3
4
5
6

ELV

Get Elevance Health Inc. Data in Excel

Get Elevance Health Inc. Data in Excel